 ESSA Pharma Inc. ESSA or the Company NASDAQ: EPIX, TSX-V: EPI, a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on February 27, 2020 in Vancouver, British Columbia, Canada the Meeting. 